Both in Pharmaceuticals
Apnimed vs Zevra Therapeutics
Over the past year APMD returned −41.3% and ZVRA returned −15.9%; their daily moves had a correlation of 0.18.
APMD −41.3% ZVRA −15.9%Growth of $1, one year, split-adjusted
| Metric | APMD | ZVRA |
|---|---|---|
| Price | $15.40 | $10.10 |
| Market cap | $641.1M | $599.8M |
| Today | −6.10% | −1.75% |
| 1 month | −28.4% | +1.1% |
| 6 months | — | +0.5% |
| Year to date | — | +12.7% |
| 1 year | — | −0.4% |
| Revenue growth (YoY) | — | +53.3% |
| Gross margin | — | 96.2% |
| Net margin | — | 21.2% |
| P/E (TTM) | — | 10.4× |
| Price / sales | — | 4.4× |
| Net cash | — | $221.6M |
| Dividend yield | — | — |
| Volatility (60d) | — | 44.1% |
| Short % of float | 10.1% | 10.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).